• Enhertu 100 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  TRASTUZUMAB DERUXTECAN	107 mg

  ATC: L01F L01FD L01FD04

• Lixiana 15 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  EDOXABAN TOSYLATE	20,205 mg

  ATC: B01A B01AF B01AF03

• Lixiana 30 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  EDOXABAN TOSYLATE	40,410 mg

  ATC: B01A B01AF B01AF03

• Lixiana 30 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  EDOXABAN TOSYLATE	40,410 mg

  ATC: B01A B01AF B01AF03

• Lixiana 60 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  EDOXABAN TOSYLATE	80,820 mg

  ATC: B01A B01AF B01AF03

• Lixiana 60 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  EDOXABAN TOSYLATE	80,820 mg

  ATC: B01A B01AF B01AF03

• Nilemdo 180 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  BEMPEDOIC ACID	180 mg

  ATC: C10A C10AX C10AX15

• Nustendi 180 mg/10 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  BEMPEDOIC ACID	180 mg
  EZETIMIBE	10 mg

  ATC: C10B C10BA C10BA10

• Vanflyta 17.7 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  QUIZARTINIB DIHYDROCHLORIDE	17,7 mg

  ATC: L01E L01EX L01EX11

• Vanflyta 26.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  QUIZARTINIB DIHYDROCHLORIDE	26,5 mg

  ATC: L01E L01EX L01EX11